Search results

Showing 1 - 10 of 22 results

1 2 3
next

GlaxoSmithKline getting high on giving

GSK is pumping £3.5m of its profits back into African healthcare. Could it be the start of a trend?

Who said it?

'That's like adding a drop of whisky to water and calling it a cocktail.' - John Hamilton, owner of Essentially Yours which makes organic hair products, says buyers of expensive shampoos are being ripped off. Even when natural extracts such as sunflower oil are listed, they'll only count as less than...

Editor's blog: We're balancing on a knife-edge

We could be heading for the dreaded double-dip. Didn't someone warn us this would happen?

Durex and Cillit Bang become unlikely bedfellows in SSL/Reckitt love-in

Reckitt Benckiser has bought the condom firm for £2.54bn - but will the deal be a good fit?

Why business is like ... Phantom traffic jams

Feeling stuck but don't know why?

Strong medicine for AstraZeneca as 1,200 UK jobs go

The UK's second-largest drugs firm AstraZeneca is to close two R&D centres with the loss of 1,200 jobs.

Gaviscon scam claims hard to digest for Reckitt Benckiser

The OFT alleges Reckitt abused its dominant market position to flog a more expensive version of Gaviscon.

Boots the Bank - coming soon?

We could be picking up an ISA along with our sun tan lotion and prescriptions, if Boots has its way...

Pfizer seeks boost with £50bn Wyeth deal

US drug company Pfizer's $68bn acquisition of Wyeth will please the City - but is it right for Pfizer?

Another 3,000 jobs to go at Rolls-Royce and AstraZeneca

Corporate giants Rolls-Royce and AstraZeneca have both announced swingeing job cuts as sales slide...

Sort results by: date | relevance

Search filters:

By Channel

  • Strategy Remove filter

By Industry Sector

  • Pharmaceuticals & Biotechnology Remove filter

Click remove filters icon to remove filters

Clear this search

Add Search Filters:

By Date

By Publication

By Article Type

1 2 3
next

Additional Information